What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

Jeeva Clinical Trials Inc

Home
United States
Manassas, VA
Jeeva Clinical Trials Inc

Call Directions Website Contact the practice

Reach us to learn more about our eClinical solution.

Jeeva's virtual control room helps biopharma and medical research sponsors execute modern clinical trials end-to-end with real-time monitoring to achieve greater efficiency, minimize risks, and cut costs with one-login, one-subscription solution. Jeeva is attacking the $26B Clinical Trial Management Systems (CTMS) market to help emerging biopharma and medtech sponsors simplify, streamline, and automate the clinical trial process for FDA approval. Our Unified B2B SaaS platform, powered by Agentic AI, enables real-time collaboration among sponsors, sites, clinical researchers, and patients to identify problems before they emerge. With 30+ trusted clients and paid pilots earned, Jeeva unifies CTMS, electronic data capture, digital patient recruitment, and engagement with intelligent automation, delivering 200% faster, 300% less burden, and 100% inclusivity.

11/02/2026

AI can help at every stage of a clinical trial, but how much can it achieve when the systems behind it remain fragmented? 🧠🔬

At DC Startup & Tech Week 2026, Harsha Rajasimha, Founder & CEO of Jeeva Clinical Trials, highlights how protocol intelligence can help connect the many moving parts of clinical research, while pointing out the limitations of building on legacy infrastructure.

The goal isn’t just to introduce AI. It’s to make it work across the clinical trial workflow.

🎥 Watch the discussion here: https://youtube.com/shorts/mtNm6wQCqZg

💬 What do you think needs to change first for AI to make a greater impact on clinical trials?

10/28/2026

Jeeva Clinical Trials is honored to be among the 16 FHITC TOPGUN Finalists recognized by the Center for Advancing Innovation (CAI). 🏆

The Future of Health Innovation Tournament Challenge (FHITC) brings together companies working to address important challenges in healthcare. For us at Jeeva, that means continuing to build AI-powered technology that helps improve clinical development workflows and supports more efficient clinical research.

Congratulations to TIMSER on being named FHITC’s first-ever overall Grand Champion, and to all the fellow finalists pushing healthcare innovation forward.

We’re glad to be part of a community working to turn promising ideas into meaningful progress for human health.

Read the full announcement: https://hubs.la/Q04Cz53M0

10/25/2026

A patient’s age is recorded as 5 in one visit and 15 in another. Would anyone catch the difference immediately?

In this Lessons from the Leap conversation, Harsha Rajasimha, Founder & CEO of Jeeva Clinical Trials, explains to Ghazenfer Mansoor how AI agents can flag inconsistencies in clinical trial data as soon as new information is entered.

By comparing current entries with a patient’s previous records, AI helps research teams spot discrepancies sooner, correct errors, and avoid relying on manual checks alone.

The result? Less time spent tracking down inconsistencies, lower operational costs, and more reliable clinical trial data.

🔗 Explore Jeeva Clinical Trials: https://hubs.la/Q04C83bc0

10/23/2026

A day of meaningful conversations, new connections, and fresh perspectives on the future of healthy aging.

Jeeva Clinical Trials was glad to be part of EPPICON 2026: Reimagining Healthy Aging, held in Foster City, California.

Harsha Rajasimha, our Founder & CEO, joined healthcare leaders, scientists, founders, and innovators for conversations around longevity, healthcare innovation, and the ideas shaping how we approach healthy aging.

Events like these offer a valuable opportunity to learn from different perspectives, exchange ideas, and connect with people working to move healthcare forward.

Thank you to the EPPICON community for bringing these conversations together. Sharing a few moments from the event!

10/22/2026

Can AI analyze 600,000 clinical trial protocols and identify critical mistakes in real time?

In this Lessons from the Leap conversation, Harsha Rajasimha, Founder & CEO of Jeeva Clinical Trials, discusses the potential of AI with Ghazenfer Mansoor.

From finding closely matching protocols to flagging potential errors, AI can handle large-scale analysis and repetitive tasks that would be difficult for humans to perform manually.

This gives clinical research teams more time to focus on important decisions while supporting better data quality and integrity.

🔗 Explore Jeeva Clinical Trials: https://hubs.la/Q04B_r1M0

10/21/2026

Living longer is one thing. Living longer with your health, independence, and quality of life is another.

Join Harsha Rajasimha, our Founder & CEO at Jeeva Clinical Trials, as he speaks with Jerry Antimano from HITLAB about rethinking healthy aging through clinical research and technology.

Harsha shares why clinical trials need to measure more than traditional health outcomes, looking at what matters in everyday life: mobility, cognition, independence, and social engagement.

He also discusses how AI and technology-enabled trials can make research more accessible, help identify patients earlier, and give researchers a better understanding of health changes over time.

The opportunity is to make clinical research work better for aging populations, with outcomes that reflect how people actually live.

▶️ Watch the full conversation: https://hubs.la/Q04BStfv0
🔗 Discover how Jeeva is advancing clinical research: https://hubs.la/Q04BSs_W0

10/19/2026

AI can identify patterns and generate recommendations, but in healthcare, human oversight remains essential.

In this conversation on Lessons from the Leap, Harsha Rajasimha, our Founder & CEO, speaks with Ghazenfer Mansoor about the responsibilities that come with building AI for healthcare and clinical research.

From human validation of AI-generated recommendations to regulatory compliance, data security, and patient privacy, the discussion highlights why trust must remain central to healthcare innovation.

Because in clinical research, smarter AI must also mean responsible AI.
🔗 Explore Jeeva Clinical Trials: https://hubs.la/Q04Bww1t0

Stay tuned for more insights on AI, clinical research, and the future of drug development.

10/17/2026

Jeeva Clinical Trials is heading to DC Startup & Tech Week 2026, a gathering of innovators, founders, and technology leaders exploring ideas shaping the future of innovation.

Harsha Rajasimha, Founder & CEO of Jeeva Clinical Trials, will be speaking at DC Tech Week on October 20 at the MLK Library and October 21 at the Virginia Tech Alexandria campus.

His participation will bring perspectives on ‘The Clinical Trial Operating System: Sovereign AI for Clinical Trials’ and the evolving role of AI in advancing clinical research and transforming clinical development workflows.

We look forward to being part of these conversations, connecting with fellow innovators, and exchanging perspectives on the future of AI in clinical research.

📅 October 19–23, 2026
📍 Washington, DC, USA

🔗 Join DC Startup & Tech Week 2026: https://hubs.la/Q04Btj710
🌐 Explore Jeeva Clinical Trials: https://hubs.la/Q04Btjbg0

10/16/2026

🚛 Could one drug submission really require a truckload of paperwork?

In this conversation on Lessons from the Leap, Harsha Rajasimha, our Founder and CEO, joins Ghazenfer Mansoor to discuss how clinical research has evolved from paper-based records to electronic regulatory submissions.

From manually digitizing trial data to preparing it for statistical analysis and regulatory review, they explore why modernizing clinical development workflows matters.

What once meant boxes and reams of paper is now increasingly handled electronically. A major shift in how clinical research moves forward!

🔗 Explore Jeeva Clinical Trials: https://hubs.la/Q04BmD3L0

Stay tuned for more conversations on the technology transforming clinical research.

10/15/2026

Rare disease drug development is entering a new chapter.

The FDA has announced its Rare Disease Framework Initiative, aiming to develop a more holistic, fit-for-purpose approach that reflects the unique challenges of rare diseases, including small patient populations and limited clinical evidence.

The initiative emphasizes patient involvement, innovative science, and greater consistency in regulatory decision-making while maintaining rigorous standards for safety and effectiveness.

For Jeeva Clinical Trials, this development highlights an important shift in rare disease research: the need for clinical trial approaches that account for the scientific and practical challenges of studying small patient populations. As the FDA seeks public feedback, the perspectives of patients, researchers, and industry will be essential in shaping this framework.

📖 Read the FDA’s full announcement: https://hubs.la/Q04Bfqxd0
🌐 Learn more about Jeeva Clinical Trials: https://hubs.la/Q04Bfqwt0

Address

10432 Balls Ford Road, Suite 300
Manassas, VA
20109

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Telephone

+1 703-968-7023

Website

https://jeevatrials.com/

Alerts

Be the first to know and let us send you an email when Jeeva Clinical Trials Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.